Literature DB >> 12965897

High levels of interleukin-1 in patients with endemic pemphigus foliaceus.

Denise Bertulucci Rocha-Rodrigues1, Giovana Paschoini, Sanivia Aparecida Lima Pereira, Marlene Antonia dos Reis, Vicente de Paula Antunes Teixeira, Virmondes Rodrigues Júnior.   

Abstract

Endemic pemphigus foliaceus (EPF) is an autoimmune disease characterized by blister formation with a loss of cohesion and infiltration of inflammatory cells. We observed that supernatants of peripheral blood mononuclear cells from patients produced significantly more interleukin-1beta (IL-1beta) than those from stimulated healthy controls. Furthermore, a Th2 bias was observed in EPF patients when the IL-5/gamma interferon ratio was analyzed. These results indicate that cells from pemphigus patients react with a vigorous proinflammatory response.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12965897      PMCID： PMC193914          DOI： 10.1128/cdli.10.5.741-743.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  24 in total

1.  Nutritonal evaluation of pemphigus foliaceus patients on long term glucocorticoid therapy.

Authors:  D F da Cunha; S F da Cunha; J P Monteiro; T P Ferreira; J A dos Santos; R A Furtado; R S Marssaro; R A Muniz; R A da Silva Gomes
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2000 Jan-Feb       Impact factor: 1.846

2.  The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research.

Authors:  S J Warren; M S Lin; G J Giudice; R G Hoffmann; G Hans-Filho; V Aoki; E A Rivitti; V Santos; L A Diaz
Journal:  N Engl J Med       Date:  2000-07-06       Impact factor: 91.245

3.  Fixation of pemphigus vulgaris and foliaceus antibodies in shedding snake epidermis.

Authors:  S A Grando
Journal:  Dermatologica       Date:  1989

4.  In vitro and in vivo expression of interleukin-1alpha and tumor necrosis factor-alpha mRNA in pemphigus vulgaris: interleukin-1alpha and tumor necrosis factor-alpha are involved in acantholysis.

Authors:  C Feliciani; P Toto; P Amerio; S M Pour; G Coscione; G Shivji; B Wang; D N Sauder
Journal:  J Invest Dermatol       Date:  2000-01       Impact factor: 8.551

5.  Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production.

Authors:  K C Bhol; A Desai; S Kumari; J E Colon; A R Ahmed
Journal:  Clin Immunol       Date:  2001-08       Impact factor: 3.969

6.  A case of pemphigus foliaceus after interferon alpha-2a therapy.

Authors:  H Niizeki; N Inamoto; K Nakamura; K Tsuchimoto; T Hashimoto; T Nishikawa
Journal:  Dermatology       Date:  1994       Impact factor: 5.366

Review 7.  Adjuvant therapy of pemphigus.

Authors:  J C Bystryn
Journal:  Arch Dermatol       Date:  1984-07

8.  Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies.

Authors:  J R Stanley; L Koulu; C Thivolet
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

9.  Further support for a role for Th2-like cytokines in blister formation of pemphigus.

Authors:  M Caproni; B Giomi; C Cardinali; E Salvatore; E Pestelli; A D'Agata; B Bianchi; P Toto; C Feliciani; P Fabbri
Journal:  Clin Immunol       Date:  2001-02       Impact factor: 3.969

Review 10.  Keratinocytes and cytokines.

Authors:  A Gröne
Journal:  Vet Immunol Immunopathol       Date:  2002-09-06       Impact factor: 2.046
View more
  7 in total

1.  Glucocorticoid sensitivity and proinflammatory cytokines pattern in pemphigus.

Authors:  Rosangela Soares Chriguer; Ana Maria Roselino; Margaret de Castro
Journal:  J Clin Immunol       Date:  2012-03-10       Impact factor: 8.317

2.  Elevated expression of NLRP1 and IPAF are related to oral pemphigus vulgaris pathogenesis.

Authors:  Reza Mahvelati Shamsabadi; Soroush Basafa; Reza Yarahmadi; Samaneh Goorani; Masood Khani; Maryam Kamarehei; Amir Hossein Kiani
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

3.  Endemic pemphigus over a century: Part II.

Authors:  Ana María Abréu-Vélez; Ana Maria Roselino; Michael S Howard; Iara J de Messias Reason
Journal:  N Am J Med Sci       Date:  2010-03

Review 4.  Fogo selvagem: endemic pemphigus foliaceus.

Authors:  Günter Hans-Filho; Valéria Aoki; Nelise Ritter Hans Bittner; Guilherme Canho Bittner
Journal:  An Bras Dermatol       Date:  2018 Sep-Oct       Impact factor: 1.896

5.  Innate immune activation as cofactor in pemphigus disease manifestation.

Authors:  Ramona A Eichkorn; Morna F Schmidt; Elias Walter; Michael Hertl; Jens Malte Baron; Jens Waschke; Amir S Yazdi
Journal:  Front Immunol       Date:  2022-07-19       Impact factor: 8.786

6.  Cytokine and Chemokines Alterations in the Endemic Form of Pemphigus Foliaceus (Fogo Selvagem).

Authors:  Rodolfo Pessato Timóteo; Marcos Vinicius Silva; Djalma Alexandre Alves da Silva; Jonatas Da Silva Catarino; Fernando Henrique Canhoto Alves; Virmondes Rodrigues Júnior; Ana Maria Roselino; Helioswilton Sales-Campos; Carlo José Freire Oliveira
Journal:  Front Immunol       Date:  2017-08-14       Impact factor: 7.561

Review 7.  Marked to Die-Cell Death Mechanisms for Keratinocyte Acantholysis in Pemphigus Diseases.

Authors:  Valéria Bumiller-Bini Hoch; Larissa Schneider; Anna Elisabeth Pumpe; Emelie Lüders; Jennifer Elisabeth Hundt; Angelica Beate Winter Boldt
Journal:  Life (Basel)       Date:  2022-02-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.